API Holdings Leadership Transition: Siddharth Shah Steps Down

API Holdings’ current CEO and cofounder, Siddharth Shah, is stepping down from his executive position. Effective August 27, 2025, he will assume the role of Vice Chairman and Director of the company.

Rahul Guha’s New Role

Rahul Guha, presently the MD and CEO of Thyrocare, is set to become the new MD and CEO of API Holdings. This change was disclosed in regulatory filings by Thyrocare on Wednesday, marking a significant leadership transition within the organisation. Guha will continue to manage operations at Thyrocare in addition to his new duties at API.

Background on Rahul Guha

Before this appointment, Guha held the title of President of Operations at API, where he played a crucial role in the integration and coordination across various group companies.

PharmEasy’s Acquisition of Thyrocare

For context, PharmEasy acquired a majority stake of 66.1% in Thyrocare for Rs 4,546 crore in June 2021. Guha’s new position underscores API’s commitment to consolidating leadership across its various sectors, especially as the company navigates a challenging funding landscape and anticipates a potential public listing.

Funding and IPO Status

API Holdings had submitted draft IPO papers in 2021 but later withdrew them due to unfavorable market conditions. PharmEasy has successfully raised approximately $1.1 billion from notable investors, including MEMG, Prosus, and Temasek. In April 2024, it secured $216 million at a significant 90% reduction in valuation, now standing at $710 million.

Changes Among PharmEasy’s Cofounders

Earlier this year, PharmEasy’s three cofounders, Dharmil Sheth, Dhaval Shah, and Hardik Dedhia, stepped back from the Bengaluru-based company. They have since launched a new venture named All Home, which has received an undisclosed investment round led by Bessemer Venture Partners, achieving a valuation exceeding $120 million. Siddharth Shah also participated in this investment round.